Pacific Biosciences of California Inc
NASDAQ:PACB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacific Biosciences of California Inc
NASDAQ:PACB
|
US |
|
M
|
Merck KGaA
DUS:MRK
|
DE |
|
M
|
Merck KGaA
XMUN:MRK
|
DE |
|
O
|
Oracle Corp
XBER:ORC
|
US |
|
S
|
Sumitomo Corp
XMUN:SUMA
|
JP |
|
V
|
Vodafone Group PLC
NASDAQ:VOD
|
UK |
|
Taikisha Ltd
F:75L
|
JP |
|
H
|
Halliburton Co
XBER:HAL
|
US |
|
O
|
Oracle Corp
DUS:ORC
|
US |
Wall St Price Targets
PACB Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PACB's stock price target?
Price Target
2.51
USD
According to Wall Street analysts, the average 1-year price target for PACB is 2.51 USD with a low forecast of 1.52 USD and a high forecast of 3.15 USD.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 28%.
